Workflow
开拓药业-B(09939) - 2023 - 中期财报
09939KINTOR PHARMA(09939)2023-09-27 08:30

Government grants relating to the purchase of property, plant and equipment are included in liabilities as deferred income and they are credited to profit or loss on a straight-line basis over the expected lives of the related assets. 附註: KINTOR PHARMACEUTICAL LIMITED INTERIM REPORT 2023 52 NOTES TO THE CONDENSED CONSOLIDATED INTERIM FINANCIAL INFORMATION 簡明綜合中期財務資料附註 | --- | --- | --- | --- | |-----------------------------------------------|---------------------------------|------------------------|------- ...